tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JOINN Laboratories Announces Board Composition and Roles

Story Highlights
JOINN Laboratories Announces Board Composition and Roles

TipRanks Cyber Monday Sale

An announcement from JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) is now available.

JOINN Laboratories has announced the composition of its board of directors and their respective roles within various committees. This update reflects the company’s commitment to structured governance and strategic oversight, which may enhance its operational efficiency and strengthen its position in the competitive pharmaceutical and biotechnology sector.

The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.

More about JOINN Laboratories (China) Co., Ltd. Class H

JOINN Laboratories (China) Co., Ltd. operates within the pharmaceutical and biotechnology industry, focusing on research and development services. The company is known for its comprehensive laboratory services, contributing to advancements in drug development and safety evaluation.

Average Trading Volume: 5,004,863

Technical Sentiment Signal: Sell

Current Market Cap: HK$21.25B

Find detailed analytics on 6127 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1